innoscripta Shares Climb 9% as Management Pushes Back on Tax Probe Fallout

innoscripta says operations are unaffected after prosecutors searched its premises over tax-credit advisory work; Warburg Research suspended its rating.

Munich-based innoscripta SE moved quickly this week to draw a line between a criminal investigation into its tax-credit advisory work and the health of its ongoing business, telling investors that day-to-day operations remain unaffected and that no transactions from the current fiscal year have been swept up in the probe.

The reassurances came after investigators searched company premises in Munich and Tutzing on Thursday, acting on two warrants issued by the Schwäbisch Gmünd district court dated August 3 and September 15. Prosecutors suspect the firm of aiding and abetting unjustified tax benefits tied to research grants claimed by certain clients — allegations centering on possible misconduct by individual staff members handling specific customer mandates.

A Sharp Reversal on the Trading Floor

The market's initial reaction was brutal. During Thursday's session the stock sank to a fresh 52-week low of EUR 31.05 before buyers stepped back in. By Friday's close the shares had recovered to EUR 41.05, a single-day gain of 9.0%, leaving investors to weigh lingering legal risk against the company's underlying earnings power.

innoscripta said it is reviewing the matter thoroughly in-house and cooperating fully with authorities, while cautioning that no final assessment of possible legal or financial consequences can be made at this stage.

The Mechanics Behind the Fee Model

What happens next may hinge on how far back the scrutiny reaches. innoscripta's revenue engine rests on a two-step approval chain: the certification office for research grants first rules on a project's basic eligibility, after which the client's local tax office sets the actual allowance. Crucially, innoscripta books its fee almost as soon as the certification office issues its notice — which means the durability of those administrative rulings is the real unknown for shareholders. If only a handful of client claims are called into question, the damage stays contained. If the underlying approval practices themselves come under fire, past revenue could be exposed.

Management's case is bolstered by several points. CEO Michael Hohenester has stressed the company's unconditional cooperation with investigators, and the firm notes that no business from fiscal 2026 is implicated so far. The allegations, moreover, concern an employee who left innoscripta several years ago. The company also points to thousands of grants already finalized by tax authorities and confirmed across numerous client audits — a track record that, if it holds up, would suggest the core earnings streams remain intact.

Where the Real Exposure Lies

The bigger threat may be reputational rather than legal. Tax-credit advisory work runs on client trust, and headlines about raids can make prospective customers think twice before filing new applications, potentially stalling new business and sapping growth momentum. Long-running tax investigations also breed uncertainty that weighs on valuation, and until the Schwäbisch Gmünd court resolves the matter, the risk of clawbacks or fresh audits lingers. Even a fiscally clean 2026 would not insulate the firm if its reputation takes a hit in the marketplace.

The searches landed at an awkward moment. Roughly a month earlier, innoscripta had reported first-half revenue growth and unveiled plans to expand into Austria in connection with that country's research premium. Executives and a major shareholder had also signaled confidence by adding to their stakes around the same time. Those operational milestones have since been pushed to the background.

Warburg Steps Aside

On the analyst front, Warburg Research suspended both its rating and price target on the stock, according to media reports — a move that reflects how difficult it has become to model the company's risk profile while the investigation is open.

Attention now turns to an upcoming product presentation to which the company has invited its shareholders. The event gives management a stage to demonstrate the strength of its technology and, if all goes well, to steer the narrative back toward operational progress. Whether the investigation stays confined to legacy matters — or widens to newer projects and additional clients — will determine if the recent calm holds or selling pressure returns.